2 October 2009 - Innova Biosciences has announced that recently appointed board member, Tim Bernard, has invested an undisclosed sum in the company.
The funds will be used to strengthen Innova's sales and marketing activities. 8 July 2009 - Innova Biosciences has announced the appointment of Tim Bernard and Lucy Block as non-executive directors. Bernard has 24 years’ experience of executive level leadership, strategic development and international sales within the life-science sector.
Block has a wealth of experience in developing start-up to early stage biotechnology companies.
13 May 2009 - Innova Biosciences and Cancer Research Technology have signed a licence agreement to develop a portfolio of conjugated antibodies against novel oncology targets.
Through the commercialisation deal, Innova Biosciences will create a collection of research tools to advance understanding of the complexities behind cancer development.
23 April 2009 - Innova Biosciences has announced sales of its Lightning-Link bioconjugation kits are growing.
